132 related articles for article (PubMed ID: 20610155)
21. A late-onset congenital myasthenic syndrome due to a heterozygous DOK7 mutation.
Bastos P; Barbosa R; Fernandes M; Alonso I
Neuromuscul Disord; 2020 Apr; 30(4):331-335. PubMed ID: 32360404
[TBL] [Abstract][Full Text] [Related]
22. Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations.
Guergueltcheva V; Müller JS; Dusl M; Senderek J; Oldfors A; Lindbergh C; Maxwell S; Colomer J; Mallebrera CJ; Nascimento A; Vilchez JJ; Muelas N; Kirschner J; Nafissi S; Kariminejad A; Nilipour Y; Bozorgmehr B; Najmabadi H; Rodolico C; Sieb JP; Schlotter B; Schoser B; Herrmann R; Voit T; Steinlein OK; Najafi A; Urtizberea A; Soler DM; Muntoni F; Hanna MG; Chaouch A; Straub V; Bushby K; Palace J; Beeson D; Abicht A; Lochmüller H
J Neurol; 2012 May; 259(5):838-50. PubMed ID: 21975507
[TBL] [Abstract][Full Text] [Related]
23. Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
Lashley D; Palace J; Jayawant S; Robb S; Beeson D
Neurology; 2010 May; 74(19):1517-23. PubMed ID: 20458068
[TBL] [Abstract][Full Text] [Related]
24. Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations.
Burke G; Hiscock A; Klein A; Niks EH; Main M; Manzur AY; Ng J; de Vile C; Muntoni F; Beeson D; Robb S
Neuromuscul Disord; 2013 Feb; 23(2):170-5. PubMed ID: 23219351
[TBL] [Abstract][Full Text] [Related]
25. Ephedrine therapy in eight patients with congenital myasthenic syndrome due to DOK7 mutations.
Schara U; Barisic N; Deschauer M; Lindberg C; Straub V; Strigl-Pill N; Wendt M; Abicht A; Müller JS; Lochmüller H
Neuromuscul Disord; 2009 Dec; 19(12):828-32. PubMed ID: 19837590
[TBL] [Abstract][Full Text] [Related]
26. Congenital myasthenic syndrome and minicore-like myopathy with DOK7 mutation.
Lorenzoni PJ; Scola RH; Kay CS; Lochmüller H; Werneck LC
Muscle Nerve; 2013 Jul; 48(1):151-2. PubMed ID: 23657916
[No Abstract] [Full Text] [Related]
27. The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations.
Rodríguez Cruz PM; Cossins J; Estephan EP; Munell F; Selby K; Hirano M; Maroofin R; Mehrjardi MYV; Chow G; Carr A; Manzur A; Robb S; Munot P; Wei Liu W; Banka S; Fraser H; De Goede C; Zanoteli E; Conti Reed U; Sage A; Gratacos M; Macaya A; Dusl M; Senderek J; Töpf A; Hofer M; Knight R; Ramdas S; Jayawant S; Lochmüller H; Palace J; Beeson D
Brain; 2019 Jun; 142(6):1547-1560. PubMed ID: 31081514
[TBL] [Abstract][Full Text] [Related]
28. Congenital Myasthenic Syndrome Caused by DOK7 Mutation in a Quinquagenarian Male with Calf Hypertrophy.
Gomathy SB; Das A; Garg A; Srivastava AK
J Clin Neuromuscul Dis; 2023 Sep; 25(1):51-54. PubMed ID: 37611271
[TBL] [Abstract][Full Text] [Related]
29. [Congenital myasthenic syndromes: difficulties in the diagnosis, course and prognosis, and therapy--The French National Congenital Myasthenic Syndrome Network experience].
Eymard B; Stojkovic T; Sternberg D; Richard P; Nicole S; Fournier E; Béhin A; Laforêt P; Servais L; Romero N; Fardeau M; Hantaï D;
Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S45-55. PubMed ID: 23452772
[TBL] [Abstract][Full Text] [Related]
30. Anticholinesterase Therapy Worsening Head Drop and Limb Weakness Due to a Novel DOK7 Mutation.
Lozowska D; Ringel SP; Winder TL; Liu J; Liewluck T
J Clin Neuromuscul Dis; 2015 Dec; 17(2):72-7. PubMed ID: 26583494
[TBL] [Abstract][Full Text] [Related]
31. Delayed diagnosis of congenital myasthenia due to associated mitochondrial enzyme defect.
Guo Y; Menezes MJ; Menezes MP; Liang J; Li D; Riley LG; Clarke NF; Andrews PI; Tian L; Webster R; Wang F; Liu X; Shen Y; Thorburn DR; Keating BJ; Engel A; Hakonarson H; Christodoulou J; Xu X
Neuromuscul Disord; 2015 Mar; 25(3):257-61. PubMed ID: 25557462
[TBL] [Abstract][Full Text] [Related]
32. Life-Long Steroid Responsive Familial Myopathy With Docking Protein 7 Mutation.
Oh SJ; King PH; Schindler A
J Clin Neuromuscul Dis; 2022 Dec; 24(2):80-84. PubMed ID: 36409338
[TBL] [Abstract][Full Text] [Related]
33. Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients.
Müller JS; Mildner G; Müller-Felber W; Schara U; Krampfl K; Petersen B; Petrova S; Stucka R; Mortier W; Bufler J; Kurlemann G; Huebner A; Merlini L; Lochmüller H; Abicht A
Neurology; 2003 Jun; 60(11):1805-10. PubMed ID: 12796535
[TBL] [Abstract][Full Text] [Related]
34. Long-term follow-up in patients with congenital myasthenic syndrome due to RAPSN mutations.
Natera-de Benito D; Bestué M; Vilchez JJ; Evangelista T; Töpf A; García-Ribes A; Trujillo-Tiebas MJ; García-Hoyos M; Ortez C; Camacho A; Jiménez E; Dusl M; Abicht A; Lochmüller H; Colomer J; Nascimento A
Neuromuscul Disord; 2016 Feb; 26(2):153-9. PubMed ID: 26782015
[TBL] [Abstract][Full Text] [Related]
35. Clinical variability of early-onset congenital myasthenic syndrome due to biallelic RAPSN mutations in Brazil.
Estephan EP; Zambon AA; Marchiori PE; da Silva AMS; Caldas VM; Moreno CAM; Reed UC; Horvath R; Töpf A; Lochmüller H; Zanoteli E
Neuromuscul Disord; 2018 Nov; 28(11):961-964. PubMed ID: 30266223
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of disease and therapeutic rescue of Dok7 congenital myasthenia.
Oury J; Zhang W; Leloup N; Koide A; Corrado AD; Ketavarapu G; Hattori T; Koide S; Burden SJ
Nature; 2021 Jul; 595(7867):404-408. PubMed ID: 34163073
[TBL] [Abstract][Full Text] [Related]
37. A founder mutation in the GMPPB gene [c.1000G > A (p.Asp334Asn)] causes a mild form of limb-girdle muscular dystrophy/congenital myasthenic syndrome (LGMD/CMS) in South Indian patients.
Polavarapu K; Mathur A; Joshi A; Nashi S; Preethish-Kumar V; Bardhan M; Sharma P; Parveen S; Seth M; Vengalil S; Chawla T; Shingavi L; Shamim U; Nayak S; Vivekanand A; Töpf A; Roos A; Horvath R; Lochmüller H; Nandeesh B; Arunachal G; Nalini A; Faruq M
Neurogenetics; 2021 Oct; 22(4):271-285. PubMed ID: 34333724
[TBL] [Abstract][Full Text] [Related]
38. Delineation of molecular characteristics of congenital myasthenic syndromes in Indian families and review of literature.
Mishra S; Nair KV; Shukla A
Clin Dysmorphol; 2023 Oct; 32(4):162-167. PubMed ID: 37646703
[TBL] [Abstract][Full Text] [Related]
39. Recurrent COLQ mutation in congenital myasthenic syndrome.
Guven A; Demirci M; Anlar B
Pediatr Neurol; 2012 Apr; 46(4):253-6. PubMed ID: 22490774
[TBL] [Abstract][Full Text] [Related]
40. Mutations in contactin-1, a neural adhesion and neuromuscular junction protein, cause a familial form of lethal congenital myopathy.
Compton AG; Albrecht DE; Seto JT; Cooper ST; Ilkovski B; Jones KJ; Challis D; Mowat D; Ranscht B; Bahlo M; Froehner SC; North KN
Am J Hum Genet; 2008 Dec; 83(6):714-24. PubMed ID: 19026398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
